MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 2 (2005), Issue 6 (June)

1. MRSA-infected external iliac artery pseudoaneurysm treated with endovascular stenting.
   Cardiovasc Intervent Radiol, 28(3): 364-6. [Abstract] [Full-text]
2. MRSA -- what is it, and how do we deal with the problem?
   Expert Opin Ther Targets, 9(2): 253-65. [Abstract] [Full-text]
3. Microfluidic genetic analysis with an integrated a-Si:H detector.
   Biomed Microdevices, 7(2): 147-52. [Abstract] [Full-text]
4. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
   Chemotherapy, 51(2): 64-9. [Abstract] [Full-text]
5. Successful outpatient treatment of sinusitis exacerbations caused by community-acquired methicillin-resistant Staphylococcus aureus.
   Otolaryngol Head Neck Surg, 132(6): 828-33. [Abstract] [Full-text]
6. The role of MRSA screening in joint-replacement surgery.
   Int Orthop, 29(3): 160-3. [Abstract] [Full-text]
7. Prevalence of Staphylococcus aureus introduced into intensive care units of a University Hospital.
   Braz J Infect Dis, 9(1): 56-63. [Abstract] [Full-text]
8. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among patients visiting the emergency room at a tertiary hospital in Brazil.
   Braz J Infect Dis, 9(1): 52-5. [Abstract] [Full-text]
9. A descriptive review of malpractice claims for health care-acquired infections in Philadelphia.
   Am J Infect Control, 33(5): 310-2. [Abstract] [Full-text]
10. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    J Antimicrob Chemother, 55(6): 995-1002. [Abstract] [Full-text]
11. Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp.
    J Antimicrob Chemother, 55(6): 1008-12. [Abstract] [Full-text]
12. Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to an increasing problem.
    J Hosp Infect, 60(3): 226-30. [Abstract] [Full-text]
13. Vancomycin-resistant enterococci: consequences for therapy and infection control.
    Clin Microbiol Infect, 11: 43-56. [Abstract] [Full-text]
14. Survey of methicillin-resistant Staphylococcus aureus strains from two hospitals in El Paso, Texas.
    J Clin Microbiol, 43(6): 2969-72. [Abstract] [Full-text]
15. Dissemination of multisusceptible methicillin-resistant Staphylococcus aureus in Singapore.
    J Clin Microbiol, 43(6): 2923-5. [Abstract] [Full-text]
16. Surveillance of Staphylococcus aureus in veterinary teaching hospitals.
    J Clin Microbiol, 43(6): 2916-9. [Abstract] [Full-text]
17. Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada.
    J Clin Microbiol, 43(6): 2830-6. [Abstract] [Full-text]
18. An extract from teak (Tectona grandis) bark inhibited Listeria monocytogenes and methicillin resistant Staphylococcus aureus.
    Lett Appl Microbiol, 41(1): 94-6. [Abstract] [Full-text]
19. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.
    Diagn Microbiol Infect Dis, 52(2): 113-22. [Abstract] [Full-text]
20. Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey.
    Clin Microbiol Infect, 11(7): 582-4. [Abstract] [Full-text]
21. MRSA at an English children's hospital from 1998 to 2003.
    Arch Dis Child, 90(7): 720-3. [Abstract] [Full-text]
22. Staphylococcus aureus endocarditis: a consequence of medical progress.
    JAMA, 293(24): 3012-21. [Abstract] [Full-text]
23. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Antimicrob Agents Chemother, 49(7): 2735-45. [Abstract] [Full-text]
24. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.
    Antimicrob Agents Chemother, 49(7): 2687-92. [Abstract] [Full-text]
25. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage.
    Clin Infect Dis, 41(2): 159-66. [Abstract] [Full-text]
26. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents.
    Int J Antimicrob Agents, 26(1): 43-9. [Abstract] [Full-text]
27. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
    Crit Care, 9(3): 257-8. [Abstract] [Full-text]
28. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
    Crit Care, 9(3): R246-50. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.